Document
Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery.
Identifier
DOI 10.5001/omj.2014.76
Contributors
Publisher
Oman Medical Specialty Board.
Gregorian
2014-07
Language
English
English abstract
The risk of thrombosis is high in patients with essential thrombocythemia. Special precaution needed for those patients who will undergo Coronary artery bypass grafting. We are reporting a 62 years old patient with ischemic heart disease who was found to have essential thrombocythemia. This report explains the preoperative management and the postoperative risks anticipated due to the treatment.
Member of
Resource URL
Citation
Ziadinov, Edem, Al-Sabti, Hilal, Al-Toubi, Malik, & Siddiqi, Mohammad Salman (2014). Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery. Oman Medical Journal, 29 (4), 294-295.
Category
Journal articles